Novartis' Drug Discovery Head Jay Bradner On What NIBR Is Investing In

 
• By Jessica Merrill
  
James Bradner
Novartis' NIBR President James Bradner
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Leadership

More from Scrip